Amicus Therapeutics, Inc.

DnB Asset Management AS FOLD

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/12/2025

Shares

46,161

Value ($000)

364

Weight

0.0%

2020 Q2 - 2025 Q3 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/12/2025	364	0.0%	46,161	9/30/2025
2025 Q2	8/12/2025	225	0.0%	39,241	6/30/2025
2025 Q1	5/15/2025	290	0.0%	35,519	3/31/2025
2024 Q4	2/12/2025	306	0.0%	32,442	12/31/2024
2024 Q3	11/12/2024	349	0.0%	32,673	9/30/2024
2024 Q2	7/5/2024	319	0.0%	32,183	6/30/2024
2024 Q1	4/12/2024	318	0.0%	27,018	3/31/2024
2023 Q4	1/4/2024	352	0.0%	24,836	12/31/2023
2023 Q3	10/13/2023	295	0.0%	24,286	9/30/2023
2023 Q2	7/10/2023	379	0.0%	30,189	6/30/2023
2023 Q1	4/20/2023	237	0.0%	21,371	3/31/2023
2022 Q4	1/12/2023	222	0.0%	18,154	12/31/2022
2022 Q3	10/11/2022	220	0.0%	21,078	9/30/2022
2022 Q2	7/8/2022	276	0.0%	25,695	6/30/2022
2021 Q4	1/12/2022	264	0.0%	22,837	12/31/2021
2021 Q3	10/15/2021	1,666	0.0%	174,278	9/30/2021
2021 Q2	7/6/2021	235	0.0%	24,380	6/30/2021
2020 Q4	1/19/2021	363	0.0%	15,728	12/31/2020
2020 Q3	10/14/2020	403	0.0%	28,550	9/30/2020
2020 Q2	7/8/2020	856	0.0%	56,768	6/30/2020